Claritev Corporation Class A CTEV

MCLEAN, Va., September 10, 2026--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable and transparent for all, today announced that Claritev Cares, its nonprofit foundation focused on expanding access to healthcare, has awarded its 2026 Rural Health Grants to Fairfield Memorial Hospital in Fairfield, Illinois, and Kodiak Community Health Center in Kodiak, Alaska.

On August 7, Claritev Corporation (NYSE:CTEV) reported second-quarter results that beat its own targets, marking five consecutive quarters of year-over-year revenue growth. Revenue for the quarter ended June 30 climbed 6.6% to $257.5 million, and management used the momentum to raise full-year guidance for the second time this year. The number that matters most, though, […]

MCLEAN, Va., August 27, 2026--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a healthcare technology, data, and insights company, today announced that members of its management team will meet with investors at the following events in September 2026:

MCLEAN, Va., August 17, 2026--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company, today announced that Marpai, Inc. (OTCQX: MRAI) has expanded its relationship with Claritev to bring comprehensive pre- and post-payment integrity capabilities to the health plans and claims it administers.

Claritev's modeled fair value has been reset from about US$36.83 to roughly US$43.83, which points to a 19% uplift in the updated price target framework. Analysts link this shift to fresh research that balances optimism around bookings, guidance and execution against concerns about leverage, antitrust headlines and the pace of improvement. As you read on, you will see how these moving pieces shape the evolving Claritev story and what that might mean for your own watchlist. Analyst Price...

Moby summary of Claritev Corporation's Q2 2026 earnings call

Claritev Corp (CTEV) beats expectations with 6.6% revenue growth and record $74 million ACV bookings in the first half of 2026, driven by claims intelligence and AI initiatives.

Claritev Corporation (NYSE:CTEV) reported second-quarter 2026 results that surpassed Wall Street expectations, driven by solid revenue growth and stronger-than-anticipated earnings. The healthcare technology company also increased its financial guidance for the full year, reflecting confidence in its operating performance.

MCLEAN, Va., August 07, 2026--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the second quarter ended June 30, 2026.

MCLEAN, Va., August 04, 2026--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will participate in the Canaccord Genuity 46th Annual Growth Conference, being held in Boston, including a fireside chat on Tuesday, August 11, 2026, at 10:00am ET.

MCLEAN, Va., July 30, 2026--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that, according to newly released 2025 data from the Centers for Medicare & Medicaid Services (CMS), the Company handled more federal Independent Dispute Resolution (IDR) claims than any other non-payer participant.